![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MBOAT2 |
Gene summary for MBOAT2 |
![]() |
Gene information | Species | Human | Gene symbol | MBOAT2 | Gene ID | 129642 |
Gene name | membrane bound O-acyltransferase domain containing 2 | |
Gene Alias | LPAAT | |
Cytomap | 2p25.1 | |
Gene Type | protein-coding | GO ID | GO:0001501 | UniProtAcc | B0AZU0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
129642 | MBOAT2 | S015 | Human | Liver | HCC | 4.28e-15 | 4.39e-01 | 0.2375 |
129642 | MBOAT2 | S016 | Human | Liver | HCC | 5.93e-16 | 4.60e-01 | 0.2243 |
129642 | MBOAT2 | C04 | Human | Oral cavity | OSCC | 9.56e-13 | 9.27e-01 | 0.2633 |
129642 | MBOAT2 | C21 | Human | Oral cavity | OSCC | 9.93e-47 | 1.50e+00 | 0.2678 |
129642 | MBOAT2 | C30 | Human | Oral cavity | OSCC | 1.06e-25 | 1.21e+00 | 0.3055 |
129642 | MBOAT2 | C46 | Human | Oral cavity | OSCC | 2.61e-06 | 2.23e-01 | 0.1673 |
129642 | MBOAT2 | C51 | Human | Oral cavity | OSCC | 1.90e-03 | 4.11e-01 | 0.2674 |
129642 | MBOAT2 | C57 | Human | Oral cavity | OSCC | 2.85e-22 | 9.57e-01 | 0.1679 |
129642 | MBOAT2 | C06 | Human | Oral cavity | OSCC | 2.88e-04 | 5.78e-01 | 0.2699 |
129642 | MBOAT2 | C08 | Human | Oral cavity | OSCC | 2.23e-09 | 5.24e-01 | 0.1919 |
129642 | MBOAT2 | LP15 | Human | Oral cavity | LP | 7.22e-04 | 8.74e-01 | 0.2174 |
129642 | MBOAT2 | LP17 | Human | Oral cavity | LP | 3.08e-02 | 4.94e-01 | 0.2349 |
129642 | MBOAT2 | SYSMH1 | Human | Oral cavity | OSCC | 1.03e-13 | 4.52e-01 | 0.1127 |
129642 | MBOAT2 | SYSMH3 | Human | Oral cavity | OSCC | 5.00e-11 | 3.80e-01 | 0.2442 |
129642 | MBOAT2 | SYSMH5 | Human | Oral cavity | OSCC | 5.12e-14 | 4.88e-01 | 0.0647 |
129642 | MBOAT2 | HTA12-23-1 | Human | Pancreas | PDAC | 2.25e-04 | 5.29e-01 | 0.3405 |
129642 | MBOAT2 | HTA12-25-1 | Human | Pancreas | PDAC | 1.56e-20 | 1.13e+00 | 0.313 |
129642 | MBOAT2 | HTA12-26-1 | Human | Pancreas | PDAC | 1.03e-14 | 6.29e-01 | 0.3728 |
129642 | MBOAT2 | HTA12-29-1 | Human | Pancreas | PDAC | 2.49e-33 | 7.13e-01 | 0.3722 |
129642 | MBOAT2 | P5_S10_cSCC | Human | Skin | cSCC | 2.37e-05 | 1.47e-01 | -0.299 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00065755 | Cervix | HSIL_HPV | cellular modified amino acid metabolic process | 16/737 | 188/18723 | 3.18e-03 | 2.89e-02 | 16 |
GO:0030258 | Colorectum | AD | lipid modification | 67/3918 | 212/18723 | 1.66e-04 | 2.27e-03 | 67 |
GO:0006575 | Colorectum | AD | cellular modified amino acid metabolic process | 59/3918 | 188/18723 | 4.80e-04 | 5.27e-03 | 59 |
GO:0006650 | Colorectum | AD | glycerophospholipid metabolic process | 83/3918 | 306/18723 | 5.40e-03 | 3.55e-02 | 83 |
GO:0006644 | Colorectum | AD | phospholipid metabolic process | 101/3918 | 383/18723 | 5.80e-03 | 3.67e-02 | 101 |
GO:00065751 | Colorectum | MSS | cellular modified amino acid metabolic process | 55/3467 | 188/18723 | 2.16e-04 | 3.01e-03 | 55 |
GO:00302582 | Colorectum | MSS | lipid modification | 57/3467 | 212/18723 | 1.64e-03 | 1.49e-02 | 57 |
GO:00065752 | Colorectum | MSI-H | cellular modified amino acid metabolic process | 25/1319 | 188/18723 | 1.61e-03 | 2.39e-02 | 25 |
GO:00302583 | Colorectum | FAP | lipid modification | 52/2622 | 212/18723 | 2.84e-05 | 6.49e-04 | 52 |
GO:0008654 | Colorectum | FAP | phospholipid biosynthetic process | 54/2622 | 253/18723 | 8.88e-04 | 9.08e-03 | 54 |
GO:00066502 | Colorectum | FAP | glycerophospholipid metabolic process | 62/2622 | 306/18723 | 1.54e-03 | 1.38e-02 | 62 |
GO:00066442 | Colorectum | FAP | phospholipid metabolic process | 74/2622 | 383/18723 | 2.24e-03 | 1.83e-02 | 74 |
GO:0006658 | Colorectum | FAP | phosphatidylserine metabolic process | 9/2622 | 25/18723 | 5.01e-03 | 3.33e-02 | 9 |
GO:00086541 | Colorectum | CRC | phospholipid biosynthetic process | 49/2078 | 253/18723 | 7.07e-05 | 1.51e-03 | 49 |
GO:00066503 | Colorectum | CRC | glycerophospholipid metabolic process | 55/2078 | 306/18723 | 2.10e-04 | 3.55e-03 | 55 |
GO:00302584 | Colorectum | CRC | lipid modification | 41/2078 | 212/18723 | 2.73e-04 | 4.38e-03 | 41 |
GO:00066443 | Colorectum | CRC | phospholipid metabolic process | 65/2078 | 383/18723 | 3.21e-04 | 4.95e-03 | 65 |
GO:00464861 | Colorectum | CRC | glycerolipid metabolic process | 64/2078 | 392/18723 | 1.01e-03 | 1.19e-02 | 64 |
GO:00066581 | Colorectum | CRC | phosphatidylserine metabolic process | 8/2078 | 25/18723 | 4.33e-03 | 3.47e-02 | 8 |
GO:0002062 | Colorectum | CRC | chondrocyte differentiation | 21/2078 | 106/18723 | 5.87e-03 | 4.33e-02 | 21 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa00561 | Colorectum | AD | Glycerolipid metabolism | 24/2092 | 63/8465 | 1.25e-02 | 4.54e-02 | 2.90e-02 | 24 |
hsa005611 | Colorectum | AD | Glycerolipid metabolism | 24/2092 | 63/8465 | 1.25e-02 | 4.54e-02 | 2.90e-02 | 24 |
hsa005612 | Colorectum | MSS | Glycerolipid metabolism | 23/1875 | 63/8465 | 6.55e-03 | 2.64e-02 | 1.62e-02 | 23 |
hsa005613 | Colorectum | MSS | Glycerolipid metabolism | 23/1875 | 63/8465 | 6.55e-03 | 2.64e-02 | 1.62e-02 | 23 |
hsa005615 | Liver | HCC | Glycerolipid metabolism | 41/4020 | 63/8465 | 3.59e-03 | 1.12e-02 | 6.22e-03 | 41 |
hsa0056112 | Liver | HCC | Glycerolipid metabolism | 41/4020 | 63/8465 | 3.59e-03 | 1.12e-02 | 6.22e-03 | 41 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MBOAT2 | SNV | Missense_Mutation | c.1306C>G | p.Leu436Val | p.L436V | Q6ZWT7 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-BH-A18P-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
MBOAT2 | SNV | Missense_Mutation | novel | c.136N>G | p.Leu46Val | p.L46V | Q6ZWT7 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
MBOAT2 | SNV | Missense_Mutation | c.439G>A | p.Glu147Lys | p.E147K | Q6ZWT7 | protein_coding | deleterious(0.01) | possibly_damaging(0.802) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
MBOAT2 | SNV | Missense_Mutation | c.1494N>G | p.Phe498Leu | p.F498L | Q6ZWT7 | protein_coding | tolerated(0.43) | benign(0) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
MBOAT2 | SNV | Missense_Mutation | c.695N>T | p.Ala232Val | p.A232V | Q6ZWT7 | protein_coding | tolerated(0.06) | benign(0.393) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
MBOAT2 | SNV | Missense_Mutation | c.128G>A | p.Arg43Gln | p.R43Q | Q6ZWT7 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AG-3892-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
MBOAT2 | SNV | Missense_Mutation | novel | c.1197N>A | p.Asn399Lys | p.N399K | Q6ZWT7 | protein_coding | tolerated(0.06) | probably_damaging(0.943) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
MBOAT2 | SNV | Missense_Mutation | c.128N>A | p.Arg43Gln | p.R43Q | Q6ZWT7 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
MBOAT2 | SNV | Missense_Mutation | c.128G>A | p.Arg43Gln | p.R43Q | Q6ZWT7 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-EI-6917-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5fluorouracil+oxaciplatina+l-folinian | SD | |
MBOAT2 | insertion | Frame_Shift_Ins | novel | c.211dupT | p.Cys71LeufsTer52 | p.C71Lfs*52 | Q6ZWT7 | protein_coding | TCGA-AM-5821-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |